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Re-visiting the evolution, dispersal and
epidemiology of Zika virus in Asia
John H.-O. Pettersson1,2,3,4, Jon Bohlin 1, Myrielle Dupont-Rouzeyrol5, Ola B. Brynildsrud 1, Kristian Alfsnes1,
Van-Mai Cao-Lormeau6,7, Michael W. Gaunt8, Andrew K. Falconar9, Xavier de Lamballerie 10,11, Vegard Eldholm1,
Didier Musso6,7 and Ernest A. Gould10
Abstract
Based on serological evidence and viral isolation, Zika virus (ZIKV) has circulated for many years relatively benignly in a
sylvatic cycle in Africa and an urban cycle in South East Asia (SEA). With the recent availability of limited but novel
Indian ZIKV sequences to add to the plethora of SEA sequences, we traced the phylogenetic history and spatio-
temporal dispersal pattern of ZIKV in Asia prior to its explosive emergence in the Paciﬁc region and the Americas.
These analyses demonstrated that the introduction and dispersal of ZIKV on the Paciﬁc islands were preceded by an
extended period of relatively silent transmission in SEA, enabling the virus to expand geographically and evolve
adaptively before its unanticipated introduction to immunologically naive populations on the Paciﬁc islands and in the
Americas. Our ﬁndings reveal new features of the evolution and dispersal of this intriguing virus and may beneﬁt
future disease control strategies.
Introduction
Zika virus (ZIKV) was ﬁrst isolated in 1947 from rhesus
monkey serum collected in the Zika Forest of Uganda
(Africa)1. Serosurveys conducted from the 1950s onwards
suggested that ZIKV circulated in several countries of
Africa and Asia. Less than 20 human infections were
conﬁrmed within the ﬁrst 60 years following the discovery
of the virus, probably because it causes mild disease in
humans and is often misdiagnosed given the existence of
several clinically similar diseases, for example, dengue or
chikungunya fever2, 3. ZIKV emerged in Africa (African
lineage) and subsequently spread through Asia (Asian
Lineage). In 2007, an Asian lineage strain of ZIKV
unpredictably caused a unique explosive epidemic on the
Paciﬁc island of Yap in Micronesia4, involving 70% of the
population. However, within months, the epidemic
subsided, and there has only been one further report of
epidemic ZIKV in Micronesia in the Kosrae State in
20165. However, in October 2013, a more recent ZIKV
strain emerged in French Polynesia (FP)6, probably fol-
lowing the accumulation of functionally important amino
acid substitutions7, 8, which were predicted to enhance
virus transmission by the primary vector species Aedes
aegypti7. Subsequently, non-vector borne transmission
(mother to child, sexual and blood transfusion transmis-
sion) was conﬁrmed with the emergence of ZIKV in the
Americas2, 9. Following its establishment on the FP
islands, ZIKV radiated eastwards and westwards10 and
subsequently emerged in Brazil before dispersing and
causing epidemics in the Americas2, 11.
Many new sequences are now available from ZIKV-
infected humans in Asia, including Bangladesh12, India13,
Indonesia14, the Philippines15, Singapore16, Thailand17,
and Vietnam18. These sequences may impact our inter-
pretation of the early evolutionary history of ZIKV in Asia.
We therefore re-visited the evolutionary events of ZIKV
from its ﬁrst emergence in Asia. Although additional
sequence data will expand our knowledge, it is already
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possible with the new data from India and South-East
Asia (SEA) to interpret the dispersal patterns of ZIKV in
terms of its geographic source, mode of spread, and time
of circulation.
Using updated phylogeographic and phylogenetic ana-
lyses, we illustrate and discuss how the epidemic pattern
in FP and the Americas contrasts strongly with the rela-
tively long-term and apparently benign circulation of
ZIKV in SEA.
Results
Bayesian phylogenetic analysis of ZIKV sequences from
Africa and Asia, including partial data from a recently
available Indian ZIKV sequence13, indicate that the Indian
virus shares a more recent ancestry with all of the other
Asian sequences than with the Malaysian sequence, which
is positioned as a sister-group to all of the other Asian
sequences (Fig. 1, branch leading to node B, Posterior
probability 0.71; Suppl. ﬁg. S1). We also performed
separate Bayesian analyses of both the partial capsid and
NS2b/NS3-genes (Suppl. ﬁg. S2 and S3, respectively). Our
results demonstrated that Indian ZIKV shared a more
recent ancestry with the SEA viruses compared to the
Malaysian virus. However, a tree based on a partial
envelope gene sequence placed the Indian virus in the
most basal position of the Asian ZIKV clade (Suppl.
ﬁg. S4). Whether this truly represents the phylogenetic
position of Indian ZIKV will require a complete genomic
analysis of the isolate and more sequence data from
geographically distant regions of India and neighbouring
countries. Subsequently, and separated by a long branch,
ZIKV then diverged to form a clade that harboured the
majority of Asian ZIKV diversity (Fig 1, node C). This was
followed by a series of diversiﬁcation events (Fig. 1, nodes
C–L) that predominantly occurred in SEA and were
characterized by frequent introductions and localized
outbreaks that probably reﬂected the increasing dis-
tribution and spread of ZIKV in the primary vector spe-
cies, i.e., Ae aegypti, and susceptible humans. Notably,
both Thailand and Vietnam experienced introductions
and outbreaks of multiple ZIKV strains throughout the
course of its evolution in SEA and have served as sources
of ZIKV in other regions (Fig. 1, Suppl. ﬁg. S1 and S5).
An inclusive phylogenetic and temporal analysis,
focusing on isolates positioned after the dispersal of ZIKV
from Africa but prior to its emergence on the Paciﬁc
islands and the Americas, was prepared. The evolutionary
rate of the Asian ZIKV lineage under a strict clock was
estimated to be 7.26 × 10−4 substitutions per site per year
(95% HPD: 6.28–8.19 × 10−4). Furthermore, the analysis
showed that the most recent common ancestor (MRCA)
of ZIKV in Asia (Fig. 1, node A) was present 5–12 years
earlier than previously estimated7, 19, ~1954–04 (95%
highest posterior density: 1948–08 to 1959–05). Then, ~2
years later, circa 1956–10 (95% HPD: 1949–09 to
1964–05), the MRCA of the Indian lineage and all sub-
sequent Asian lineage ZIKV emerged (Fig. 1, node B),
surprisingly implying the introduction of Indian ZIKV
from an Asian rather than an African source. Subse-
quently, following a silent period of ~40 years, ZIKV
appeared in SEA in early 1997 (95% HPD: 1994–09 to
1999–03; Fig. 1, node C). It should also be noted that the
MRCA of the Micronesian and Philippine sequences was
estimated to have been present in Asia ca. 1997 (95%
HPD: 1995–07 to 1999–12; Suppl. ﬁg. S5). Thus, the
ancestor of these two emergent viruses was possibly
present in SEA and evolved relatively silently for at least
10 years prior to the Micronesian epidemic in 2007.
Following the emergence of ZIKV in SEA (node C), there
was a period of circulation of ~15 years (Fig. 1, nodes
C–L) prior to its introduction and emergence on the FP
islands (Fig. 1, nodes M1–M4) in mid-2012 (95% HPD:
2011–12 to 2013–01). The introduction of ZIKV from FP
into America followed about 1 year later, ~2013–03 (95%
HPD: 2012–11 to 2013–06) (Suppl. table 1; Suppl. ﬁg. S5).
When the Indian sequence data were excluded, the results
of the temporal estimates were conﬁrmed by using the
HPD values that overlapped in the two analyses, which
were supported by time-regression analyses including all
data (Suppl. ﬁg. S5–S7).
Discussion
Following its ﬁrst isolation in April 1947 from a sentinel
rhesus monkey in the canopy of the African Zika Forest of
Uganda1, ZIKV was isolated again in 1948 in the same
forest but this time from Ae africanus, an indigenous
African sylvatic mosquito1. These observations suggest
that in Africa, ZIKV circulates between sylvatic Aedes
species mosquitoes and monkeys that inhabit the forest
canopy, which does not exclude other possible transmis-
sion cycles. Subsequent epidemiological and serological
studies have revealed that ZIKV was probably also pre-
valent and widespread in African towns and villages
during the 1950s2, 20, 21. Since it is now known that both
dengue viruses (DENVs) and ZIKV adapted from sylvatic
to urban transmission cycles, likely due to the increasing
Ae aegypti population density in urban districts of SEA,
our observations provide a rational explanation for how it
was possible for ZIKV to be isolated in 1966 from
domestic Ae aegypti in populous areas of the Malaysian
peninsula22. Importantly, attempts in the 1950s to isolate
ZIKV from a wide range of mosquitoes in sylvatic envir-
onments in Malaysia22 and other Asian countries did not
result in the identiﬁcation of additional strains of ZIKV,
implying that the Malaysian virus was not signiﬁcantly
established in the sylvatic Asian environment, which also
appears to be the case for ZIKV in the Paciﬁc and the
Americas; that is, ZIKV is not signiﬁcantly sylvatic except
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in Africa. Nevertheless, following the detection of ZIKV in
Malaysia, subsequent serosurveys conducted between
1952 and 1989, in which 189 of 1011 tests were reported
as ZIKV positive2, 23–25, support the concept of wide-
spread distribution of ZIKV in SEA2, 19, 26–29. Impor-
tantly, these early studies were performed using the most
speciﬁc serological assay, viz., neutralization against high
virus challenge doses (>50 LD50 to >1000 LD50) in mice,
to reveal a high incidence of neutralizing antibody
responses in residents of Malaya (19% and 75%)23, 25,
Borneo (18%)23 and India (16.8%)24.
Why did ZIKV disperse so successfully throughout Asia
for so many years without appearing to have caused major
epidemics30? Clearly, the very low frequency of clinically
apparent ZIKV infections and the difﬁculty in clinically
discriminating between infections caused by DENV, chi-
kungunya virus (CHIKV), and ZIKV were major factors in
the failure to recognize the presence of ZIKV infections.
Second, the inapparent spread of endemic ZIKV
throughout SEA resulted in the emergence of low-level
herd immunity to the virus. Third, antigenically related
ﬂaviviruses, including DENV, West Nile virus (WNV),
Japanese encephalitis virus, Wesselsbron virus, and
Stratford virus, circulating throughout SEA contributed a
background of cross-protective reactivity to ZIKV that
might have dampened ZIKV transmission. By contrast,
with the exception of several islands in the Western
Paciﬁc region that have experienced outbreaks of JEV,
DENV was the only human pathogenic ﬂavivirus known
to have caused outbreaks in islands further east in the
Fig. 1 Illustrative phylogenetic tree of ZIKV evolution and dispersal in the Asian region. Coloured circles on the terminal nodes represent the
country of infection on the map. White lines indicate the main routes of spread. Letters within the gray circles (A–M4) refer to diversiﬁcation events
throughout the period of ZIKV evolution in Asia and the Paciﬁc islands, which correspond to the dates of divergence (in bold) and highest posterior
density for each tMRCA. A comprehensive tree is provided in the Supplementary Materials (Suppl. ﬁg. S5)
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Paciﬁc prior to the arrival of epidemic ZIKV. Moreover, it
is a widely held view that immunity to DENV alone does
not protect humans against infection with ZIKV2. Thus,
the evolving ZIKV was probably introduced to popula-
tions of immunologically naive inhabitants on most of the
Paciﬁc islands, leading to the explosive epidemics that
have now been reported widely7. Several human ﬂavi-
viruses, including DENVs, are known to circulate in the
Americas. Thus, the situation in Brazil and neighbouring
South American countries should differ signiﬁcantly from
that described in Oceania because several human patho-
genic ZIKV-related ﬂaviviruses circulate in Brazil,
including DENVs, St. Louis encephalitis virus (SLEV),
yellow fever virus (YFV), Ilheus virus (ILHV), Rocio virus
(ROCV), and others. Why, therefore, was ZIKV able to
cause explosive epidemics in the Americas in the presence
of this potential immune background? The most likely
explanation is that, with the exception of YFV, which
circulates primarily in the sylvatic environment in the
Americas, and DENV, which is not believed to stimulate
protective immunity to ZIKV2, these other ZIKV-related
ﬂaviviruses are not commonly transmitted by domestic Ae
aegypti and therefore do not circulate primarily in the
urban environment favored by ZIKV.
Moreover, a serosurvey of Indian human sera using the
mouse protection test revealed a high incidence of pro-
tective immunity against DENV-1 (40.4%: 72/196),
DENV-2 (20.2%: 38/188), WNV (35.0%: 123/351), and
ZIKV (16.8%: 33/196), while none of 588 sera neutralized
YFV and only a few neutralized the American ﬂaviviruses,
ILHV (1.4%: 3/206) or SLEV (2.8%: 6/211)24. These results
suggest that the presence of an antibody-mediated cross-
protection between ZIKV and either YFV or the Amer-
ican ﬂaviviruses is relatively unlikely. In addition, while
ROCV caused local epidemics in coastal areas of São
Paulo, Brazil from 1973 to 1980, it has subsequently dis-
appeared from this region of Brazil30. Furthermore, WNV,
which has only recently been detected in Brazil, does not
yet appear to have become established as a signiﬁcant
pathogen in Latin America31. It should also be empha-
sized that even following the epidemics in the Paciﬁc and
subsequent spread of ZIKV to the Americas, Asia has
experienced relatively small ZIKV outbreaks compared to
the explosive and clinically apparent epidemics in the
Paciﬁc and the Americas32.
Thus, ZIKV epidemics in FP and the Americas have
occurred in the presence of a high background immunity
to DENV. However, as noted above, it is a widely held
view that immunity to DENV does not necessarily protect
humans against infection with ZIKV2. How and when did
African ZIKV gain access to SEA? Like DENV and
CHIKV, the major transmission vector of ZIKV is Ae
aegypti, the domestic descendant of the sylvatic African
Ae africanus2, 33 and the primary conduit for the
introduction of DENV and CHIKV to Asia via ships
trading out of East Africa during the 18th–20th cen-
turies34–36. Thus, by analogy, ZIKV is also likely to have
been introduced to Asia, from Africa, in infected humans
and/or Ae aegypti, to which ZIKV had adapted, via the
same shipping routes. This argument is also supported by
contemporary evidence of frequently reported cases of
ZIKV being introduced to non-tropical countries by
infected individuals returning from areas in the tropics
where epidemic ZIKV was known to be circulating37.
Based on an earlier study7 with a similar estimated evo-
lutionary rate (Median: 6.30 × 10−4; 95% HPD: 5.48 × 10−4
to 7.10 × 10−4) to that of the present study, the African
and Asian ZIKV lineages were estimated to have diverged
in ~1834, which is consistent with reports of other Ae
aegypti- transmitted viruses, namely, DENV and CHIKV,
being introduced via ships trading between East Africa
through India to SEA34, 38.
Recently, ZIKV was isolated from a patient in northern
India. A neighbour-joining analysis of the partial envelope
gene of this virus implied that the Indian sequence was
basal in the Asian ZIKV clade13. To investigate this fur-
ther, we concatenated sequences of the partial capsid,
envelope and NS2b/NS3 genes of the Indian ZIKV isolate
and analyzed the data in a Bayesian phylogenetic frame-
work. Our results suggested that the Indian sequence was
not basal to the Malaysian virus isolated in 1966 (Suppl.
ﬁg. S1). By contrast, our analysis suggests that ZIKV could
have been introduced to India from SEA, rather than vice
versa. Although the currently available sequence data do
not robustly resolve the Indian versus Malaysian ancestry,
the concept of the introduction of ZIKV from SEA to
India seems plausible given that ZIKV also appears to
have been introduced to Bangladesh from SEA (Fig. 1;
Suppl. ﬁg. S1 and S5). In this context, the highest inci-
dence of human sera that neutralized ZIKV was collected
from towns in the Ahmedabad district (north-west India)
in the state from which the NIV1720741 strain used in the
present analysis was isolated in 201624. This state may,
therefore, represent a pocket of endemicity containing
divergent ZIKV strains in that region.
Our phylogenetic and temporal analyses suggest that
ZIKV was ﬁrst introduced to SEA during the 1950s, and
then dispersed both eastwards and westwards ~5–12
years earlier than was previously predicted7, 19. Our esti-
mate is also compatible with serological studies con-
ducted in Malaysia, India, Indonesia, the Philippines,
Thailand and Vietnam, indicating that ZIKV was present
in these countries between 1952 and 19542 (and refer-
ences therein). Based on the current phylogenies (Fig. 1;
Suppl. ﬁg. S1 and S5), ZIKV was potentially ﬁrst intro-
duced from Africa to the Malaysian–Indonesian region
and subsequently to India. However, although many new
sequences have been published during the past few years,
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it is still not possible to determine precisely whether any
particular country in SEA has played a major role com-
pared with other countries in the evolution and dispersal
of ZIKV in SEA.
Between 1954 and 1976, no recorded human clinical
ZIKV cases in Asia were conﬁrmed using serological tests
or virus isolation procedures. Hence, it is likely that ZIKV
remained undetected because it was primarily a sub-
clinical disease and diagnostic tests for ZIKV were not
routinely performed. Then, in 1977 and 1978 three and
four febrile patients on Java, Indonesia, were diagnosed
with ZIKV infection, respectively39. Over 35 years later,
ZIKV was isolated from a patient from Sumatra, Indo-
nesia14. It is possible that ZIKV remained undetected in
the Malaysian–Indonesian region for a long time, circu-
lating mainly between Ae aegypti and human hosts,
causing sporadic sub-clinical or mildly clinical human
infections, while evolving and adapting to its vector spe-
cies. Thus, since the late 1950s, ZIKV appears to have
circulated silently in SEA according to serosurvey data.
The analyses suggest that the MRCA of the Malaysian and
Indian isolates is approximately 40 years earlier than that
of the Micronesian/Philippine and all subsequent isolates
(Fig. 1, node B vs C, Suppl. ﬁg. S5). However, without
further sequence data from these neglected areas of Asia,
it will continue to be difﬁcult to identify precisely where
ZIKV was circulating and, potentially, causing human
ZIKV infections. Nevertheless, serological studies suggest
that ZIKV may have been present in the Indian–SEA
region earlier than the 1950s23, 25, 40.
It is clear that ZIKV has circulated without recognition
for many years in Asia. This is supported by evidence
from serology, virus isolation2 and phylogenetic analyses,
all of which have shown that the ancestral Asian virus
continued to evolve and circulate (Suppl. ﬁg. S1 and S5)
prior to and after its unexpected emergence as an epi-
demic virus on Yap island, Micronesia, in 20074. In fact,
during a period of 14 years, 1997–2011 (Fig. 1, nodes
C–L), this ancestral lineage of Asian ZIKV appears to
have dispersed between several other countries in SEA.
Notably, Thailand and Vietnam were possibly the source
of ZIKV in other regions of Asia. For example, Thailand
appears to have been the source of ZIKV in Singapore,
which experienced a large outbreak in 201616, and in
Bangladesh (Suppl. ﬁg S5). Thus, it is likely that different
countries in SEA have experienced different epidemiolo-
gical situations. Whereas, the Philippines seems to have
had a single strain of ZIKV circulating for several years,
Thailand and Vietnam appear to have experienced mul-
tiple introductions and “waves” of ZIKV that have swept
across these countries (Suppl. ﬁg S1 and S5) followed by
re-occurring outbreaks29, 41. Consequently, following the
isolated Micronesian epidemic in 2007, ZIKV continued
to circulate and evolve in the SEA–Indian-region32, 42
before causing a large-scale epidemic in FP in 2013/2014.
ZIKV was subsequently introduced into the Americas,
apparently via Brazil7, 8, 11.
It is also believed that the ZIKV strain that emerged on
Yap Island, Micronesia, did not disperse widely beyond
Micronesia. Although the reasons for its failure to spread
have not been identiﬁed, there are several possible
explanations. First, the Micronesian lineage pre-dates the
FP lineage by at least six years, during which four unique
and functionally signiﬁcant amino acid substitutions
emerged in the FP lineage, i.e., T777M, V763M, S139N,
and M/T2634V7. The ﬁrst three of these unique sub-
stitutions has been shown to have functions relating either
to receptor attachment or virus fusion activity with cell
membranes43. These substitutions could therefore have
an impact on the relative transmission efﬁciency of the FP
lineage compared with earlier Asian lineage sequences7.
Second, in support of this interpretation, the unique
S139N substitution, ﬁrst identiﬁed in 20167, emerged in
FP and was detected in virtually every descendant lineage,
suggesting a possible link with microcephaly. Subse-
quently, the unique S139N substitution was associated
with increased ZIKV infectivity in humans and enhanced
fetal mouse microcephaly44. Third, the relatively small
human population size and density on the Micronesian
islands and limited connectivity with other Paciﬁc islands
might have limited the likelihood of ZIKV dispersal to
other distant regions of the Paciﬁc. Fourth, a mutation
(A188V) was subsequently shown to potentially con-
tribute to the apparently increased transmission efﬁciency
of ZIKV45. However, more than one amino acid sub-
stitution appears to determine the transmission efﬁciency
since the A188V substitution is not consistently asso-
ciated with it. For example, A188V is the ancestral state
for this described substitution in Africa, but the only
outbreak reported in Africa was caused by a strain
belonging to the Asian lineage46. Nevertheless, the data, in
total, are consistent with the hypothesis that ZIKV has
circulated, potentially silently in the presence of other
related human pathogenic ﬂaviviruses, in sub-Saharan
Africa and SEA for many decades47–49.
Our analysis also indicates that the MRCA of the lineage
that eventually led to the large outbreak on FP might have
existed and potentially been introduced in June 2012 (95%
HPD: 2011–12 to 2013–01), i.e., ~1 year before the ﬁrst
detection of ZIKV in FP in October 20136, 9, 50, 51. Based
on the observed short divergence times between nodes
M1 and N (Suppl. table 1; Suppl. ﬁg. S5), a potential
explanation for the rapid dispersal of ZIKV in the Paciﬁc
and the Americas could be interpreted as being due to
relatively low levels of herd immunity in the populations.
In addition, a similar cryptic period of about 1 year, before
its appearance as an epidemic virus, was predicted for the
introduction of ZIKV into Brazil11. Whether this reﬂects
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the relatively mild nature of ZIKV infections and conse-
quently low viraemic levels in the majority of the infected
population is an intriguing subject for mathematical
modelers.
In summary, following its emergence in Asia, after being
introduced from Africa, ZIKV circulated as a relatively
benign virus in Asia for several decades. ZIKV then
emerged in Oceania and the Americas and, largely
because of its association with central nervous system
malformations in neonates, especially microcephaly, it
became an international public health concern. This raises
at least two important questions, (i) how did ZIKV cir-
culate successfully throughout Asia during its apparent
silent period between 1966 and 2006 and (ii) what are the
major determinants of the increased epidemicity of ZIKV
in the Paciﬁc and the Americas. With regard to the former
question, several possible explanations have been pro-
posed for these differences in the epidemicity of ZIKV in
Asia compared to that of ZIKV in the Paciﬁc and the
Americas: Stochastic evolution52, adaptive evolution7,
NS1 protein enhancement45, S139 enhancement7, 44, and
contrasting levels of background immunity due to cross-
protective antibodies2. Each of these factors could con-
tribute to the overall differences in the transmission efﬁ-
ciency. However, the relatively high background cross-
reactive antigenicity and/or immunity, which are likely
present in Asia, contrasting with the relatively low
equivalent antigenicity and/or immunity in the Paciﬁc and
the Americas, in combination with the key amino acid
mutations in the ZIKV genome, can potentially explain
the different epidemiological patterns between Asia on
the one hand and the Paciﬁc and Americas on the other.
Materials and methods
Partial and complete genome ZIKV sequences were
retrieved from the NCBI GenBank (www.ncbi.nlm.nih.
gov/genbank/) focusing on Asian lineage ZIKV isolates.
Initially, all available complete genomes (as of October
2017) were retrieved. Sequences collected from the Paciﬁc
islands and the Americas were subsampled to reduce the
data load. Subsequently, partial phylogenetically infor-
mative sequences were collected around the Indian–SEA
region and added to the dataset. These sequences were
then used to construct two curated open reading-frame
datasets (sequence information is available in Supple-
mentary Table S2); (i) one open reading-frame dataset
included 89 sequences, representing 5 from the African
lineage and 84 of the Asian lineage; (ii) the other open
reading-frame dataset included 84 sequences of Asian
lineage only. The datasets were aligned with Mafft
v.7.26653, keeping the reading-frame consistent with
amino-acid positions, and were visualized and edited in
AliView54. All subsequent analyses were performed with a
generalized time-reversible nucleotide substitution model
with four gamma distributed rate variation categories and
a proportion of invariant sites, as selected by jModeltest
v.255.
To analyze the phylogenies of the 84 Asian lineage
strains, including the novel Indian sequence, a Bayesian
phylogenetic tree was computed using MrBayes v.3.2.656
with the dataset including the 5 African ZIKV lineage
strains as an out-group. Two parallel runs with four
Metropolis-coupled chains were initiated for 5M Markov
chain Monte Carlo generations using the previously
determined models of nucleotide evolution with default
ﬂat Dirichlet priors, sampling every 1000 generations and
discarding the ﬁrst 25% as burn-in before computing a
consensus tree. Since only partial sequences of the Indian
isolate were available, it is likely that phylogenetic place-
ment was also examined by constructing three separate
trees based on either the capsid (453 bp), envelope (773
bp), or NS2b/NS3 (1393 bp) sequence alignments.
To estimate the evolutionary rates and time to the most
recent common ancestor for the Asian lineage, BEAST
v.1.8.357 was employed. Initially, the temporal structure
was assessed with TempEst V.1.5.1 (http://tree.bio.ed.ac.
uk/software/tempest/) plus MM-type robust regression58.
Subsequently, a path-stone and stepping-stone model-test
was performed59, determining that a strict molecular
clock with a non-informative continuous-time Markov
chain (CTMC) prior and a Bayesian skyline coalescent
tree prior with a piecewise-constant demographic model
best suited the dataset based on Bayes factor evaluation.
Based on the resultant Bayesian phylogenetic tree, which
included African ZIKV as outgroup sequences, all Asian
ZIKV lineages except the Malaysian 1966-sequence were
annotated as a monophyletic clade. The robustness of the
dating was also evaluated by excluding the Indian
sequence. Using the models and parameters suggested by
the model-test, two analyses were run in parallel for 100
M MCMC generations, sampling every 10,000 genera-
tions per analysis. The convergence of the two runs was
assessed with Tracer 1.6 (http://tree.bio.ed.ac.uk/
software/tracer/). Tree- and log-ﬁles were combined
with LogCombiner (BEAST-package57), and a maximum-
clade credibility tree was computed with TreeAnnotator
(BEAST-package57) after discarding the ﬁrst 10 M
MCMC generations of each run. The resultant consensus
tree was visualized and edited in FigTree v.1.4.1 (http://
tree.bio.ed.ac.uk/software/ﬁgtree/). All computations
were run using the CIPRES computational cluster60.
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